{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:28:18Z","timestamp":1793500098396,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010552","name":"Generalitat de Catalunya Departament de Salut","doi-asserted-by":"publisher","award":["100046TC21_2022 INV-1 00046"],"award-info":[{"award-number":["100046TC21_2022 INV-1 00046"]}],"id":[{"id":"10.13039\/501100010552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["101046314"],"award-info":[{"award-number":["101046314"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund Plus","doi-asserted-by":"publisher","award":["100046TC21_2022 INV-1 00046"],"award-info":[{"award-number":["100046TC21_2022 INV-1 00046"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund Plus","doi-asserted-by":"publisher","award":["PID2021-125493OB-I00"],"award-info":[{"award-number":["PID2021-125493OB-I00"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010336","name":"Fundaci\u00f3 Privada Daniel Bravo Andreu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["2020-029886-I\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["2020-029886-I\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["CEX2018-000806-S"],"award-info":[{"award-number":["CEX2018-000806-S"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2021-125493OB-I00"],"award-info":[{"award-number":["PID2021-125493OB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["MCIN\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["MCIN\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021953","name":"Arkansas Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021953","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.micinf.2024.105423","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T17:34:34Z","timestamp":1726594474000},"page":"105423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["High-resolution kinetics and cellular determinants of SARS-CoV-2 antibody response over two years after COVID-19 vaccination"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0448-3404","authenticated-orcid":false,"given":"Roc\u00edo","family":"Rubio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00eddac","family":"Maci\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Barrios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0301-3344","authenticated-orcid":false,"given":"Alfons","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5447-6803","authenticated-orcid":false,"given":"Luis M.","family":"Molinos-Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1220-015X","authenticated-orcid":false,"given":"Natalia","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3043-7612","authenticated-orcid":false,"given":"Mar","family":"Canyelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lara-Escandell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Planchais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Santamaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Carolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3704-9874","authenticated-orcid":false,"given":"Luis","family":"Izquierdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3277-3107","authenticated-orcid":false,"given":"Ruth","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5105-9836","authenticated-orcid":false,"given":"Gemma","family":"Moncunill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlota","family":"Doba\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7935","key":"10.1016\/j.micinf.2024.105423_bib2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41586-022-05398-2","article-title":"A multinational Delphi consensus to end the COVID-19 public health threat","volume":"611","author":"Lazarus","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2024.105423_bib3","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMoa2115481","article-title":"Duration of protection against mild and severe disease by covid-19 vaccines","volume":"386","author":"Andrews","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.micinf.2024.105423_bib4","first-page":"1","article-title":"Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave","author":"Tan","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.micinf.2024.105423_bib5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijid.2022.12.025","article-title":"Time from last immunity event against infection during Omicron-dominant period in Malaysia","volume":"128","author":"Yang","year":"2023","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.micinf.2024.105423_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1095129","article-title":"Persistent humoral and CD4+ TH cell immunity after mild SARS-COV-2 infection-The CoNAN long-term study","volume":"13","author":"Schnizer","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.micinf.2024.105423_bib7","first-page":"1","article-title":"Durability of vaccine-induced and natural immunity against COVID-19: a narrative review","author":"Pooley","year":"2023","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.micinf.2024.105423_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/science.abm0829","article-title":"mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern","volume":"374","author":"Goel","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.micinf.2024.105423_bib9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.immuni.2024.01.017","article-title":"SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase","volume":"57","author":"Srivastava","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.micinf.2024.105423_bib10","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167955","article-title":"Durability of immune responses to the booster mRNA vaccination against COVID-19","author":"Arunachalam","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.micinf.2024.105423_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(22)00880-5","article-title":"The benefit of vaccination after previous SARS-CoV-2 infection in the omicron era","author":"Boaventura","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.micinf.2024.105423_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00662-22","article-title":"Longitudinal follow-up of the immunity to SARS-CoV-2 in health care workers in Argentina: persistence of humoral response and neutralizing capacity after sputnik V vaccination","author":"Castro","year":"2023","journal-title":"mSphere"},{"key":"10.1016\/j.micinf.2024.105423_bib13","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3389\/fimmu.2023.1156758","article-title":"Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection","volume":"14","author":"Escudero-P\u00e9rez","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.micinf.2024.105423_bib14","article-title":"Hybrid immunity expands the functional humoral footprint of both mRNA and vector-based SARS-CoV-2 vaccines","volume":"4","author":"Kaplonek","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.micinf.2024.105423_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-024-03304-3","article-title":"Correlates of protection and determinants of SARS-CoV-2 breakthrough infections 1 year after third dose vaccination","volume":"22","author":"Mart\u00edn P\u00e9rez","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.micinf.2024.105423_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-022-02570-3","article-title":"Sustained seropositivity up to 20.5 months after COVID-19","volume":"20","author":"Doba\u00f1o","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.micinf.2024.105423_bib17","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220638","article-title":"Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2","volume":"219","author":"Planchais","year":"2022","journal-title":"J Exp Med"},{"key":"10.1016\/j.micinf.2024.105423_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/imm.13551","article-title":"Eleven-month longitudinal study of antibodies in SARS-CoV-2 exposed and na\u00efve primary health care workers upon COVID-19 vaccination","volume":"167","author":"Doba\u00f1o","year":"2022","journal-title":"Immunology"},{"key":"10.1016\/j.micinf.2024.105423_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v057.i12","article-title":"Building bivariate Tables: the compareGroups package for R","volume":"57","author":"Subirana","year":"2014","journal-title":"J Stat Software"},{"key":"10.1016\/j.micinf.2024.105423_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.trsl.2021.10.004","article-title":"Spike-based COVID-19 immunization increases antibodies to nucleocapsid antigen","volume":"240","author":"Doba\u00f1o","year":"2022","journal-title":"Transl Res"},{"key":"10.1016\/j.micinf.2024.105423_bib21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3343\/alm.2021.41.6.577","article-title":"Comparison of SARS-CoV-2 antibody responses and seroconversion in COVID-19 patients using twelve commercial immunoassays","volume":"41","author":"Yun","year":"2021","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.micinf.2024.105423_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abe0367","article-title":"Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients","volume":"5","author":"Iyer","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.micinf.2024.105423_bib23","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJMc2101667","article-title":"Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine","volume":"384","author":"Krammer","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.micinf.2024.105423_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1220600","article-title":"Longitudinal study of humoral immunity against SARS-CoV-2 of health professionals in Brazil: the impact of booster dose and reinfection on antibody dynamics","volume":"14","author":"Franco-Luiz","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.micinf.2024.105423_bib25","article-title":"Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells","volume":"2","author":"Cohen","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.micinf.2024.105423_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-014-0117-2","article-title":"A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine","volume":"12","author":"White","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.micinf.2024.105423_bib27","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/infdis\/jiac117","article-title":"Biphasic waning of hemagglutination inhibition antibody titers after influenza vaccination in children","volume":"226","author":"Xiong","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.micinf.2024.105423_bib28","article-title":"Anti-SARS-CoV-2 IgM secondary response was suppressed by preexisting immunity in vaccinees: a prospective, longitudinal cohort study over 456 days","volume":"11","author":"Xu","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.micinf.2024.105423_bib29","article-title":"Antibody and B Cell responses to SARS-CoV-2 infection and vaccination: the end of the beginning","volume":"19","author":"R\u00f6ltgen","year":"2023","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.micinf.2024.105423_bib30","article-title":"Long-term persistence of SARS-CoV-2 neutralizing antibody responses after infection and estimates of the duration of protection","volume":"41","author":"Lau","year":"2021","journal-title":"EClin Med"},{"key":"10.1016\/j.micinf.2024.105423_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2009.09.046","article-title":"Structure and function of immunoglobulins","volume":"125","author":"Schroeder","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.micinf.2024.105423_bib32","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.1038\/s41467-023-41941-z","article-title":"Viral kinetics of sequential SARS-CoV-2 infections","volume":"14","author":"Kissler","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.micinf.2024.105423_bib33","doi-asserted-by":"crossref","first-page":"1201.e1","DOI":"10.1016\/j.cmi.2023.05.020","article-title":"Durability and determinants of anti-SARS-CoV-2 spike antibodies following the second and third doses of mRNA COVID-19 vaccine","volume":"29","author":"Yamamoto","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.micinf.2024.105423_bib34","article-title":"Germinal centre-driven maturation of B cell response to mRNA vaccination","author":"Kim","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.micinf.2024.105423_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-32298-w","article-title":"Antibody affinity and cross-variant neutralization of SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 following third mRNA vaccination","volume":"13","author":"Bellusci","year":"2022","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.micinf.2024.105423_bib36","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41577-020-00436-4","article-title":"Not just antibodies: B cells and T cells mediate immunity to COVID-19","volume":"20","author":"Cox","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.micinf.2024.105423_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276241","article-title":"Cellular interferon-gamma and interleukin-2 responses to SARS-CoV-2 structural proteins are broader and higher in those vaccinated after SARS-CoV-2 infection compared to vaccinees without prior SARS-CoV-2 infection","volume":"17","author":"Sedegah","year":"2022","journal-title":"PLoS One"},{"issue":"7830","key":"10.1016\/j.micinf.2024.105423_bib38","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses","volume":"586","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2024.105423_bib39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","article-title":"The T cell immune response against SARS-CoV-2","volume":"23","author":"Moss","year":"2022","journal-title":"Nat Immunol"},{"key":"10.1016\/j.micinf.2024.105423_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/imr.13089","article-title":"Immunological memory to SARS\u2010CoV \u20102 infection and COVID \u201019 vaccines","author":"Sette","year":"2022","journal-title":"Immunol Rev"},{"key":"10.1016\/j.micinf.2024.105423_bib41","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.3390\/diagnostics13071280","article-title":"Virus-specific stem cell memory CD8+ T cells may indicate a long-term protection against evolving SARS-CoV-2","volume":"13","author":"Aleksova","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.micinf.2024.105423_bib42","doi-asserted-by":"crossref","DOI":"10.1172\/JCI145476","article-title":"SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals","volume":"131","author":"Kared","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.micinf.2024.105423_bib43","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.3389\/fimmu.2022.1031254","article-title":"Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination","volume":"13","author":"Paniskaki","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.micinf.2024.105423_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-27674-x","article-title":"Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts","volume":"13","author":"Kundu","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.micinf.2024.105423_bib45","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T Cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.micinf.2024.105423_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-023-41342-2","article-title":"Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk","volume":"14","author":"P\u00e9rez-Al\u00f3s","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.micinf.2024.105423_bib47","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1056\/NEJMoa066092","article-title":"Duration of humoral immunity to common viral and vaccine antigens","volume":"357","author":"Amanna","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.micinf.2024.105423_bib48","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.it.2020.04.001","article-title":"Improving vaccine-induced immunity: can baseline predict outcome?","volume":"41","author":"Tsang","year":"2020","journal-title":"Trends Immunol"}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457924001655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457924001655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:04:19Z","timestamp":1778799859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286457924001655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1286457924001655"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2024.105423","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-resolution kinetics and cellular determinants of SARS-CoV-2 antibody response over two years after COVID-19 vaccination","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2024.105423","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS on behalf of Institut Pasteur.","name":"copyright","label":"Copyright"}],"article-number":"105423"}}